Zacks Research Analysts Reduce Earnings Estimates for AMETEK

AMETEK, Inc. (NYSE:AME) – Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for shares of AMETEK in a research note issued on Tuesday, February 18th. Zacks Research analyst R. Department now expects that the technology company will post earnings of $1.69 per share for the quarter, down from their prior estimate of $1.71. The consensus estimate for AMETEK’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for AMETEK’s Q2 2025 earnings at $1.75 EPS, Q3 2025 earnings at $1.79 EPS, Q4 2025 earnings at $1.90 EPS, FY2025 earnings at $7.13 EPS, Q1 2026 earnings at $1.78 EPS, Q2 2026 earnings at $1.88 EPS, Q3 2026 earnings at $1.95 EPS, Q4 2026 earnings at $2.04 EPS, FY2026 earnings at $7.64 EPS and FY2027 earnings at $8.15 EPS.

A number of other equities analysts have also weighed in on the company. Robert W. Baird decreased their target price on AMETEK from $200.00 to $197.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Mizuho upped their target price on AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. KeyCorp upped their target price on AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. BNP Paribas upgraded AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price on the stock in a research note on Thursday, January 16th. Finally, Bank of America upgraded AMETEK from a “neutral” rating to a “buy” rating and increased their price objective for the company from $195.00 to $225.00 in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $204.67.

AMETEK Price Performance

Shares of NYSE AME opened at $188.82 on Thursday. The firm has a market capitalization of $43.68 billion, a P/E ratio of 31.84, a P/E/G ratio of 2.69 and a beta of 1.16. The company has a quick ratio of 0.75, a current ratio of 1.24 and a debt-to-equity ratio of 0.15. The stock’s 50-day simple moving average is $182.97 and its two-hundred day simple moving average is $177.69. AMETEK has a twelve month low of $149.03 and a twelve month high of $198.33.

AMETEK (NYSE:AME) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.02. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.82 billion. During the same period in the previous year, the company posted $1.68 EPS. The firm’s revenue for the quarter was up 1.8% compared to the same quarter last year.

Institutional Investors Weigh In On AMETEK

Institutional investors and hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc lifted its holdings in AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company’s stock worth $35,000 after buying an additional 187 shares during the period. Itau Unibanco Holding S.A. lifted its holdings in AMETEK by 62.6% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company’s stock worth $34,000 after buying an additional 77 shares during the period. Banque Transatlantique SA purchased a new position in shares of AMETEK in the 4th quarter valued at approximately $37,000. AdvisorNet Financial Inc lifted its stake in shares of AMETEK by 1,176.5% in the 4th quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company’s stock valued at $39,000 after purchasing an additional 200 shares during the period. Finally, Geneos Wealth Management Inc. lifted its stake in shares of AMETEK by 42.9% in the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after purchasing an additional 70 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.

Insider Activity at AMETEK

In other AMETEK news, insider Emanuela Speranza sold 6,747 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total value of $1,321,737.30. Following the completion of the sale, the insider now owns 30,460 shares in the company, valued at approximately $5,967,114. This trade represents a 18.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Tony J. Ciampitti sold 16,210 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $197.01, for a total value of $3,193,532.10. Following the completion of the sale, the insider now owns 49,490 shares of the company’s stock, valued at approximately $9,750,024.90. This trade represents a 24.67 % decrease in their position. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by company insiders.

AMETEK Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be issued a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, March 14th. This is a boost from AMETEK’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 0.66%. AMETEK’s dividend payout ratio is currently 18.89%.

AMETEK declared that its board has approved a share buyback plan on Friday, February 7th that permits the company to repurchase $1.25 billion in shares. This repurchase authorization permits the technology company to buy up to 2.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.